Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Randomized, Modified Double-blind, Multi-centric, Comparative Study, to Evaluate Non-inferiority, Immunogenicity and Safety Cholera Vaccine Hillchol® (BBV131) to the Comparator Vaccine Shanchol™ and Hillchol® Lot Consistency

NCT05732766 is registered in ClinicalTrials.gov with Bharat Biotech International Limited as lead sponsor.

NCT NCT05732766
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05732766 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Randomized, Modified Double-blind, Multi-centric, Comparative Study, to Evaluate Non-inferiority, Immunogenicity and Safety Cholera Vaccine Hillchol® (BBV131) to the Comparator Vaccine Shanchol™ and Hillchol® Lot Consistency
Lead sponsor
Bharat Biotech International Limited
Phase
Phase 3
Overall status
Unknown status
Start date
February 4, 2023
Completion date
August 31, 2023
Enrollment
1,800 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

cholera